Linde India Ltd
Linde India Limited, a subsidiary of BOC Group,UK (owns 75% stake in the co), is primarily engaged in manufacture of industrial and medical gases and construction of cryogenic and non cryogenic air separation plants.[1]
- Market Cap ₹ 54,370 Cr.
- Current Price ₹ 6,376
- High / Low ₹ 8,781 / 5,202
- Stock P/E 123
- Book Value ₹ 443
- Dividend Yield 0.07 %
- ROCE 16.9 %
- ROE 12.3 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 22.0%
Cons
- Stock is trading at 14.4 times its book value
- The company has delivered a poor sales growth of 7.12% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Industrial Gases
Part of BSE 500 BSE 200 Nifty 500 BSE MidCap Nifty MNC
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 15m | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,428 | 1,491 | 1,567 | 1,825 | 2,033 | 2,192 | 1,762 | 1,471 | 2,112 | 3,136 | 2,769 | 2,485 | 2,403 | |
| 1,167 | 1,214 | 1,337 | 1,539 | 1,705 | 1,866 | 1,347 | 1,096 | 1,564 | 2,371 | 2,066 | 1,720 | 1,625 | |
| Operating Profit | 261 | 277 | 230 | 287 | 328 | 326 | 415 | 375 | 548 | 765 | 702 | 765 | 778 |
| OPM % | 18% | 19% | 15% | 16% | 16% | 15% | 24% | 25% | 26% | 24% | 25% | 31% | 32% |
| 59 | 11 | 22 | 34 | 11 | 23 | 862 | 44 | 348 | 109 | 77 | 68 | 53 | |
| Interest | 74 | 103 | 90 | 116 | 116 | 103 | 86 | 6 | 3 | 6 | 7 | 13 | 14 |
| Depreciation | 129 | 181 | 162 | 195 | 206 | 199 | 177 | 176 | 181 | 253 | 201 | 214 | 218 |
| Profit before tax | 117 | 4 | 1 | 10 | 16 | 47 | 1,013 | 236 | 711 | 614 | 571 | 606 | 599 |
| Tax % | 34% | -51% | -4,164% | -31% | -17% | 29% | 28% | 34% | 28% | 13% | 25% | 26% | |
| 77 | 5 | 23 | 13 | 19 | 33 | 727 | 156 | 514 | 536 | 426 | 448 | 441 | |
| EPS in Rs | 9.07 | 0.63 | 2.75 | 1.57 | 2.22 | 3.93 | 85.27 | 18.24 | 60.26 | 62.82 | 49.99 | 52.51 | 51.75 |
| Dividend Payout % | 17% | 237% | 27% | 48% | 45% | 38% | 12% | 16% | 22% | 19% | 24% | 23% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 7% |
| 3 Years: | 6% |
| TTM: | -11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 92% |
| 5 Years: | 30% |
| 3 Years: | 14% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 55% |
| 3 Years: | 22% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| Last Year: | 12% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 |
| Reserves | 1,342 | 1,304 | 1,307 | 1,310 | 1,322 | 1,342 | 2,052 | 2,118 | 2,606 | 3,029 | 3,349 | 3,694 |
| 1,528 | 1,564 | 1,388 | 1,445 | 1,282 | 1,199 | 108 | 7 | 24 | 22 | 21 | 42 | |
| 1,011 | 926 | 883 | 722 | 680 | 759 | 970 | 1,048 | 1,287 | 1,246 | 1,324 | 1,289 | |
| Total Liabilities | 3,966 | 3,880 | 3,664 | 3,563 | 3,369 | 3,385 | 3,215 | 3,259 | 4,003 | 4,382 | 4,780 | 5,110 |
| 1,665 | 2,201 | 2,158 | 2,573 | 2,498 | 2,162 | 2,035 | 1,989 | 1,869 | 1,762 | 1,822 | 1,925 | |
| CWIP | 744 | 356 | 577 | 80 | 36 | 44 | 53 | 17 | 68 | 225 | 483 | 975 |
| Investments | 15 | 15 | 15 | 15 | 15 | 0 | 0 | 2 | 2 | 16 | 27 | 27 |
| 1,542 | 1,308 | 915 | 895 | 821 | 1,179 | 1,127 | 1,251 | 2,064 | 2,378 | 2,448 | 2,183 | |
| Total Assets | 3,966 | 3,880 | 3,664 | 3,563 | 3,369 | 3,385 | 3,215 | 3,259 | 4,003 | 4,382 | 4,780 | 5,110 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 229 | 271 | 242 | 293 | 252 | 376 | 327 | 339 | 589 | 629 | 440 | 584 | |
| -385 | -264 | -58 | -128 | -59 | -73 | 981 | -54 | 98 | -306 | -539 | -1,305 | |
| 169 | -8 | -222 | -80 | -261 | -216 | -1,193 | -201 | -28 | -119 | -109 | -112 | |
| Net Cash Flow | 12 | -1 | -37 | 85 | -68 | 87 | 115 | 84 | 659 | 203 | -208 | -833 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74 | 75 | 78 | 71 | 63 | 61 | 79 | 101 | 73 | 47 | 63 | 57 |
| Inventory Days | 104 | 153 | 141 | 102 | 91 | 66 | 57 | 72 | 37 | 22 | 32 | 69 |
| Days Payable | 424 | 541 | 466 | 447 | 348 | 293 | 327 | 477 | 312 | 156 | 235 | 349 |
| Cash Conversion Cycle | -246 | -313 | -247 | -274 | -194 | -166 | -190 | -303 | -202 | -87 | -139 | -224 |
| Working Capital Days | -66 | -81 | 16 | -70 | -69 | -81 | -22 | 6 | -3 | -9 | -12 | -29 |
| ROCE % | 5% | 3% | 3% | 4% | 5% | 6% | 11% | 10% | 17% | 21% | 17% | 17% |
Documents
Announcements
- Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 30 June 2025. 2d
-
Board Meeting Outcome for Updates On Outcome Of Board Meeting Held On 7 August 2025
2d - Q1 FY26 financial results; revenue Rs 5,711M, profit Rs 1,071M; ongoing SEBI investigations disclosed.
-
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30 June 2025
25 Jul - Board meeting on 7 Aug 2025 to approve Q1 FY26 unaudited financial results.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
22 Jul - Letter no. Sect/50 dated 22 July 2025 enclosing therewith public notice published by the Company in connection with Notice of its 89th Annual General Meeting, …
-
Communication To Members- Letter Under Regulation 36(1)(B) Of The SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations')
22 Jul - Notice of 89th AGM on 14 Aug 2025 and Annual Report 2024-25 available online for shareholders.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from nse
Business Segment
Gas and Related Products: It comprises of pipeline gas supplies to large industrial customers like primary steel, glass and chemical industries, supply of liquefied gases through Cryogenic tankers (Bulk) to cater to demand across a wide range of industrial sectors and compressed gas supply in cylinders (Packaged Gas) for meeting smaller demand for gases mainly across fabrication, manufacturing and construction industry.
Healthcare business: It provides high quality gases for pharmaceutical use such as medical oxygen, synthetic air and nitrous oxide in addition to providing state of the art medical gas distribution systems to major hospitals.
Project Engineering division (PED): It comprises the business of design, engineering, supply, installation, testing and commissioning of Air Separation plants and related projects on turnkey basis. [1][2]